Orthobiologic company Kolosis partnered with MTF Biologics to launch Kore Fiber, which is an aseptically-processed cortical bone matrix with significant handling characteristics, according to a Feb. 17 news release.
“I have used MTF allografts extensively over 20 years, in both general orthopedic cases as well as spine surgery cases,” Dr. Russo said. “The aseptic processing methods coupled with the favorable handling characteristics of Kore provide an excellent option for bone grafting.”
Kore Fiber is available in four different sizes of moldable fiber and three sizes of strips, according to the company.
More articles on biologics:
Massachusetts, Rhode Island practices to forge 60-plus physician group
3 spine surgeons debut high-speed drills with Mazor robot
Former Medtronic exec to lead Zimmer Biomet’s spine spinoff
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
